false
0001676163
0001676163
2024-07-09
2024-07-09
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of The Securities
Exchange Act of 1934
Date of report (Date of earliest event reported):
July 9, 2024
SS INNOVATIONS INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
Florida |
|
333-216054 |
|
47-3478854 |
(State or Other Jurisdiction
of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
1600 SE 15th Street, #512
Fort Lauderdale, Florida |
|
33316 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (954) 478-1410
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
Title of each Class |
|
Trading Symbol |
|
Name of each exchange on which registered |
None |
|
N/A |
|
N/A |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
As used in this Current Report on Form 8-K (this ”Report”),
the terms “SSi,” “the Company,” “we,” “us” and “our”
refer to SS Innovations International, Inc. and its subsidiaries.
Item 8.01 Other Events.
On July 9, 2024, we issued a press release announcing
that the Company that its SSi Mantra Surgical Robotic System has been installed at Baidya & Banskota Hospital in Kathmandu, Nepal
marking the first time a surgical robotic system has been installed in Nepal.
A copy of the press release is included as Exhibit
99.1 to this Report.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: July 9, 2024 |
SS INNOVATIONS INTERNATIONAL, INC. |
|
|
|
|
By: |
/s/ Sudhir Srivastava |
|
|
Sudhir Srivastava, M.D.
Chairman and Chief Executive Officer |
2
Exhibit 99.1
SSi Mantra Expands Global Footprint: Nepal's
First Surgical Robot Set to Transform Healthcare Sector
| ● | Baidya & Banskota (B&B) Hospital Installs Nepal's First Surgical Robotic System, India made
SSi Mantra |
| ● | SSi Mantra integrates cutting edge advancements in robotic surgery, offering surgeons unparalleled
precision and control for improved patient outcomes |
| ● | SS Innovations helps reinforce India's position as a global hub for technological innovation in healthcare |
Fort Lauderdale, FL., July 9, 2024 -
SS Innovations International, Inc. (the Company” or “SS Innovations”) (OTC: SSII), developer of innovative
surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population,
today announced that its SSi Mantra Surgical Robotic System (“SSi Mantra”) has been installed at Baidya & Banskota
Hospital (“B&B Hospital”) in Kathmandu, Nepal marking the first time a surgical robotic system has been installed in
Nepal. SSi Mantra’s cutting-edge technology underscores B&B Hospital’s commitment to delivering superior healthcare
and helps position the institution at the forefront of medical innovation in the region.
The collaboration between SS Innovations and B&B
Hospital represents a breakthrough in Nepalese healthcare. Under the leadership of Prof. Dr. Jagdish Lal Baidya, Dr. Niraj Lal Baidya
and Dr. Saroj Lal Baidya, and support from Prof. Dr. Ashok Kumar Banskota B&B Hospital in Gwarko, Lalitpur has become the first hospital
in Nepal to install this advanced surgical robotic system, which we believe will greatly benefit many patients across that country.
The SSi Mantra is known for its precision, minimally
invasive capabilities and advanced technology, helping to ensure enhanced surgical outcomes and quicker recovery times for patients. By
integrating this state-of-the-art system, B&B Hospital will be able to offer its surgical patients access to the highest standards
of medical treatment.
Commenting on the installation of SSi Mantra in
Nepal, President and COO of SS Innovations, Dr Vishwa Srivastava, said “We are extremely proud of being able to provide
this much-needed technology to our Himalayan neighbors in the north. We have full faith that the excellent doctors at B&B Hospital
will help elevate the level of care in Nepal. This placement is a powerful reminder of what inspired us to develop our SSi Mantra Surgical
Robotic System and make it affordable and accessible for all.”
On the installation of the SSi Mantra robotic
system in B&B Hospital, Prof. Dr. Jagdish Lal Baidya, Co-Founder of B&B Hospital, commented “We are thrilled to
announce that B&B Hospital has become the first institution in Nepal to install the cutting-edge SSi Mantra robotic surgical system.
This advanced technology will assist in performing several key specialty surgeries, greatly enhancing patient care. SSi Mantra's groundbreaking
technology has the potential to transform the way we perform surgeries, significantly benefiting our patients with its minimally invasive
approach and superior precision. At B&B Hospital, we are always working towards improving the techniques and technologies to make
surgeries safe, minimally invasive, and cost-effective.”
On the installation of the SSi Mantra robotic
system in B&B Hospital, Prof. Dr. Ashok K Banskota, Co-Founder of B&B Hospital, commented - “Very happy and momentous
occasion in the history of the development of surgery in Nepal, and in particular of the services at B&B Hospital. Hopefully, many
Nepali patients will now be able to avail of the expertise underlying the advantages provided by robotic surgery technology. Hearty congratulations
to all who have worked tirelessly to make this service available for the first time in Nepal. It is a long cherished dream now fulfilled
for our leader in Surgery/ Urology, Prof. Dr Jagdish Lal Baidya! I have great hopes for the success of this venture.”
B&B Hospital and SS Innovations intend to
collaborate with the goal of setting a new standard for healthcare in Nepal by providing patients with cutting-edge robotic surgical options.
This collaboration underscores a shared vision of decentralizing excellence and making innovative medical solutions accessible to all,
irrespective of socioeconomic and geographical barriers.
About SS Innovations International, Inc.:
SS Innovations International, Inc. (OTC: SSII)
is a developer of innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible
to a larger part of the global population. SSII’s product range includes its proprietary “SSi Mantra” surgical robotic
system, and “SSi Mudra” its wide range of surgical instruments capable of supporting a variety of surgical procedures including
robotic cardiac surgery. SSII’s business operations are headquartered in India and SSII has plans to expand the presence of its
technologically advanced, user-friendly, and cost-effective surgical robotic solutions, globally. For more information, visit SSII’s
website at ssinnovations.com or LinkedIn for updates.
About SSI Mantra:
Supporting advanced, affordable, and accessible
robotic surgery, the SSi Mantra Surgical Robotic System provides the capabilities for multi-specialty usage including cardiothoracic,
head and neck, gynecology, urology, general surgery and more. With its modular arm configuration, 3D 4K vision open-console design and
superior ergonomics, the system engages with the surgeon and surgical teams to improve safety and efficiency during procedures. The SSi
Mantra system has received Indian Medical Device regulatory approval (CDSCO) and is clinically validated in India in more than 70 different
types of surgical procedures. SS Innovations has commenced the regulatory approval process in the United States and the European Union
and anticipates receiving FDA approval to market and CE Mark approval in 2025.
About Baidya & Banskota (B&B) Hospital:
Established in November 1997 through the collaborative
efforts of Dr. Jagdish Lal Baidya and Dr. Ashok K. Banskota, Baidya & Banskota (B&B) Hospital has emerged as a cornerstone of
healthcare in Nepal. Strategically situated across 2.26 acres, the hospital and its educational arm, B&B Medical Institute, offer
a comprehensive range of services to the community. These include emergency care, general medical and surgical treatments, as well as
specialized services across various subspecialties. Widely recognized nationwide for its orthopedic and urological expertise, the hospital
is rapidly evolving into a cutting-edge multi-specialty and super specialty institution. It boasts advanced capabilities in diagnostics
(including expanded laboratory services), imaging (such as X-ray, mammography, CT scan, MRI, and ultrasound), and therapeutic interventions
(such as laparoscopic procedures, endourology, laser surgery, GI endoscopy, arthroscopic surgeries, joint replacements, and plastic reconstructive
surgery). B&B Hospital employs 120 doctors and over 800 dedicated staff members committed to patient care. Annually, the hospital
serves more than 90,000 outpatient registrations and over 9,000 inpatient admissions.
Forward-Looking Statements:
This press release may contain statements that
are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995.
The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,”
“intend,” “may,” “plan,” “project,” “should,” “could,” “seek,”
“designed,” “potential,” “forecast,” “target,” “objective,” “goal,”
or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future
events or SS Innovations International’s future financial performance and involve known and unknown risks, uncertainties and other
factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future
results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.
Follow us on:
LinkedIn: https://www.linkedin.com/company/ssinnovationsgroup/
YouTube: https://www.youtube.com/@ssinnovations
For media inquiries, please contact:
press@ssinnovations.org
+1-212-739-0300
v3.24.2
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 2 such as Street or Suite number
+ References
+ Details
Name: |
dei_EntityAddressAddressLine2 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14a -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
AVRA Medical Robotics (PK) (USOTC:AVMR)
Historical Stock Chart
From Jun 2024 to Jul 2024
AVRA Medical Robotics (PK) (USOTC:AVMR)
Historical Stock Chart
From Jul 2023 to Jul 2024